RA Medical Systems Story
RMEDDelisted Stock | USD 0.54 0.00 0.00% |
About 56% of RA Medical's investor base is looking to short. The analysis of current outlook of investing in RA Medical Systems suggests that many traders are alarmed regarding RA Medical's prospects. RA Medical's investor sentiment overview provides quick insight into current market opportunities from investing in RA Medical Systems. The current market sentiment, together with RA Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use RA Medical Systems stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RA Medical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of RMED daily returns and investor perception about the current price of RA Medical Systems as well as its diversification or hedging effects on your existing portfolios.
RMED |
Requested story not found. it has been either deleted or moved. View all stories for RA Medical Systems.
RA Medical Latest Timeline
RA Medical is listed for 0.54. About 37.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. RA Medical Systems recorded a loss per share of 35.78. The entity last dividend was issued on the 17th of November 2020. The firm had 1:50 split on the 3rd of October 2022.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the RA Medical Systems information on this page should be used as a complementary analysis to other RA Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world |